STOCK TITAN
  1. Home
  2. Sec-filings
  3. INO
  4. [SCHEDULE 13G/A] Inovio Pharmaceuticals, Inc. SEC Filing

[SCHEDULE 13G/A] Inovio Pharmaceuticals, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock INO logo
Inovio Pharmaceu

NASDAQ:INO

INO Rankings

#7121 Ranked by Market Cap
N/A Ranked by Dividends

INO Latest News

Jul 7, 2025
INOVIO to Present at Upcoming Scientific Conference
Jul 3, 2025
INOVIO Announces Pricing of $25 Million Public Offering
Jul 2, 2025
INOVIO Announces Proposed Public Offering
May 13, 2025
INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights
Apr 30, 2025
INOVIO to Present at Upcoming Scientific and Investor Conferences

INO Latest SEC Filings

Jul 7, 2025
[8-K] Inovio Pharmaceuticals, Inc. Reports Material Event
Jul 3, 2025
[424B5] Inovio Pharmaceuticals, Inc. Prospectus Supplement (Debt Securities)
Jul 2, 2025
[424B5] Inovio Pharmaceuticals, Inc. Prospectus Supplement (Debt Securities)
Jul 1, 2025
[Form 4] Inovio Pharmaceuticals, Inc. Insider Trading Activity

INO Stock Data

70.83M
50.67M
0.68%
36.6%
15.3%
Biotechnology
Pharmaceutical Preparations
Link
United States
PLYMOUTH MEETING